Ketamine Research in Acute Suicidal Ideation
One of the most clinically meaningful findings in modern psychiatry.
This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.
Findings
- Rapid (within hours) reduction in suicidal ideation in TRD samples.
- Effect appears partially independent of broader depression response.
- Effect duration variable — days to weeks without further intervention.
Clinical context
Ketamine for acute suicidality is a bridge, not a destination. Hospitalization, safety planning, and ongoing care remain central.
Crisis resources
If you or someone you love is in crisis, call or text 988 (US) or visit our crisis resources page.
Educational content only. Not medical advice. Discuss any treatment decisions with a qualified clinician.
Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.